InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by CLACKSON TIMOTHY P, Directeur, Président et CEO. Insider active across 3 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 6 reports have been published. Total volume traded: €45k. The latest transaction was disclosed on 31 May 2022 — Don. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
031,553 shares0
Common Stock
SEC:0001209191-22-038758:0·
04,500 shares0
Common Stock
SEC:0000899243-22-021662:0·
€22,5062,600 shares@ €8.6562100.0% of flow
Common Stock
SEC:0000899243-21-049429·
Ideal exit: 17 Sept 2022 (T+270)
€22,5062,600 shares@ €8.656250.0% of flow
Common Stock
SEC:0000899243-21-049429:0·
Ideal exit: 17 Sept 2022 (T+270)
02,750 shares0
Common Stock
SEC:0000899243-21-025092·
02,750 shares0
Common Stock
SEC:0000899243-21-025092:0·
6 of 6 declarations
About CLACKSON TIMOTHY P
Timothy P. Clackson is Director, President and CEO at Forma Therapeutics Holdings, Inc., Theseus Pharmaceuticals, Inc., and Elevation Oncology, Inc. In this role, he oversees the strategic and operational direction of these companies. Timothy brings extensive experience in the biopharmaceutical sector, contributing to the growth and innovation of these firms.
